Olivier Heinzlef

8PUBLICATIONS
67CO-AUTHORS
Gene and molecular therapyRehabilitationPredictive and prognostic markersEpidemiological methodsPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|Jun 05, 2026
A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple Sclerosis.

|May 05, 2026
Differences in Use of Disease-Modifying Therapies Between Patients With Late-Onset and Adult-Onset Relapsing-Remitting Multiple Sclerosis.

|Sep 04, 2025
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.

Antoine Gavoille, Mikail Nourredine, Fabien Rollot

|Jul 30, 2025
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.

Antoine Gavoille, Emmanuelle Leray, Romain Marignier

|Jul 16, 2025
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.

Camille Robin, Fabien Rollot, Mathilde Lefort

Pageof 2

Frequent Collaborators

6 joint publications

Guillaume Mathey

6 joint publications

Bertrand Bourre

6 joint publications

Jean-Philippe Camdessanché

6 joint publications

Jonathan Ciron